Fig. 8From: MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-αOverexpression of miR-505 inhibits TGF-α expression in vivo. Immunohistochemical analysis demonstrated a significant reduction of TGF-α expression in the HSA-miR-505 group (b) compared with the mock group (a) in nude mice tumor tissuesBack to article page